Global Vaginal Fungi Infections Treatment Supply, Demand and Key Producers, 2024-2030

Page: 131

Published Date: 14 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Vaginal Fungi Infections Treatment market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Vaginal candidiasis is usually treated with antifungal medicine. For most infections, the treatment is an antifungal medicine applied inside the vagina or a single dose of fluconazole taken by mouth.

This report studies the global Vaginal Fungi Infections Treatment demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Vaginal Fungi Infections Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaginal Fungi Infections Treatment that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Vaginal Fungi Infections Treatment total market, 2019-2030, (USD Million)
Global Vaginal Fungi Infections Treatment total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Vaginal Fungi Infections Treatment total market, key domestic companies and share, (USD Million)
Global Vaginal Fungi Infections Treatment revenue by player and market share 2019-2024, (USD Million)
Global Vaginal Fungi Infections Treatment total market by Type, CAGR, 2019-2030, (USD Million)
Global Vaginal Fungi Infections Treatment total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Vaginal Fungi Infections Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Bausch Health Companies Inc, ANI Pharmaceuticals, Hikma Pharmaceuticals Plc, Lupin Limited, Mycovia Pharmaceuticals, Glenmark Pharmaceuticals Limited, Unique Pharmaceuticals and PEPTONIC medical AB, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaginal Fungi Infections Treatment market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Vaginal Fungi Infections Treatment Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Vaginal Fungi Infections Treatment Market, Segmentation by Type
Fluconazole
Nystatin
Flucytosine
Others

Global Vaginal Fungi Infections Treatment Market, Segmentation by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Companies Profiled:
Pfizer Inc.
Bausch Health Companies Inc
ANI Pharmaceuticals
Hikma Pharmaceuticals Plc
Lupin Limited
Mycovia Pharmaceuticals
Glenmark Pharmaceuticals Limited
Unique Pharmaceuticals
PEPTONIC medical AB
Aurobindo Pharma Limited
Dr. Reddy's Laboratories
SCYNEXIS

Key Questions Answered
1. How big is the global Vaginal Fungi Infections Treatment market?
2. What is the demand of the global Vaginal Fungi Infections Treatment market?
3. What is the year over year growth of the global Vaginal Fungi Infections Treatment market?
4. What is the total value of the global Vaginal Fungi Infections Treatment market?
5. Who are the major players in the global Vaginal Fungi Infections Treatment market?

Table of Contents

1 Supply Summary
    1.1 Vaginal Fungi Infections Treatment Introduction
    1.2 World Vaginal Fungi Infections Treatment Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Vaginal Fungi Infections Treatment Total Market by Region (by Headquarter Location)
        1.3.1 World Vaginal Fungi Infections Treatment Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Vaginal Fungi Infections Treatment Market Size (2019-2030)
        1.3.3 China Vaginal Fungi Infections Treatment Market Size (2019-2030)
        1.3.4 Europe Vaginal Fungi Infections Treatment Market Size (2019-2030)
        1.3.5 Japan Vaginal Fungi Infections Treatment Market Size (2019-2030)
        1.3.6 South Korea Vaginal Fungi Infections Treatment Market Size (2019-2030)
        1.3.7 ASEAN Vaginal Fungi Infections Treatment Market Size (2019-2030)
        1.3.8 India Vaginal Fungi Infections Treatment Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Vaginal Fungi Infections Treatment Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Vaginal Fungi Infections Treatment Major Market Trends

2 Demand Summary
    2.1 World Vaginal Fungi Infections Treatment Consumption Value (2019-2030)
    2.2 World Vaginal Fungi Infections Treatment Consumption Value by Region
        2.2.1 World Vaginal Fungi Infections Treatment Consumption Value by Region (2019-2024)
        2.2.2 World Vaginal Fungi Infections Treatment Consumption Value Forecast by Region (2025-2030)
    2.3 United States Vaginal Fungi Infections Treatment Consumption Value (2019-2030)
    2.4 China Vaginal Fungi Infections Treatment Consumption Value (2019-2030)
    2.5 Europe Vaginal Fungi Infections Treatment Consumption Value (2019-2030)
    2.6 Japan Vaginal Fungi Infections Treatment Consumption Value (2019-2030)
    2.7 South Korea Vaginal Fungi Infections Treatment Consumption Value (2019-2030)
    2.8 ASEAN Vaginal Fungi Infections Treatment Consumption Value (2019-2030)
    2.9 India Vaginal Fungi Infections Treatment Consumption Value (2019-2030)

3 World Vaginal Fungi Infections Treatment Companies Competitive Analysis
    3.1 World Vaginal Fungi Infections Treatment Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Vaginal Fungi Infections Treatment Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Vaginal Fungi Infections Treatment in 2023
        3.2.3 Global Concentration Ratios (CR8) for Vaginal Fungi Infections Treatment in 2023
    3.3 Vaginal Fungi Infections Treatment Company Evaluation Quadrant
    3.4 Vaginal Fungi Infections Treatment Market: Overall Company Footprint Analysis
        3.4.1 Vaginal Fungi Infections Treatment Market: Region Footprint
        3.4.2 Vaginal Fungi Infections Treatment Market: Company Product Type Footprint
        3.4.3 Vaginal Fungi Infections Treatment Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Vaginal Fungi Infections Treatment Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Vaginal Fungi Infections Treatment Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Vaginal Fungi Infections Treatment Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Vaginal Fungi Infections Treatment Consumption Value Comparison
        4.2.1 United States VS China: Vaginal Fungi Infections Treatment Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Vaginal Fungi Infections Treatment Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Vaginal Fungi Infections Treatment Companies and Market Share, 2019-2024
        4.3.1 United States Based Vaginal Fungi Infections Treatment Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Vaginal Fungi Infections Treatment Revenue, (2019-2024)
    4.4 China Based Companies Vaginal Fungi Infections Treatment Revenue and Market Share, 2019-2024
        4.4.1 China Based Vaginal Fungi Infections Treatment Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Vaginal Fungi Infections Treatment Revenue, (2019-2024)
    4.5 Rest of World Based Vaginal Fungi Infections Treatment Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Vaginal Fungi Infections Treatment Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Vaginal Fungi Infections Treatment Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Vaginal Fungi Infections Treatment Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Fluconazole
        5.2.2 Nystatin
        5.2.3 Flucytosine
        5.2.4 Others
    5.3 Market Segment by Type
        5.3.1 World Vaginal Fungi Infections Treatment Market Size by Type (2019-2024)
        5.3.2 World Vaginal Fungi Infections Treatment Market Size by Type (2025-2030)
        5.3.3 World Vaginal Fungi Infections Treatment Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Vaginal Fungi Infections Treatment Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Hospital Pharmacies
        6.2.2 Retail Pharmacies
        6.2.3 Online Pharmacies
    6.3 Market Segment by Application
        6.3.1 World Vaginal Fungi Infections Treatment Market Size by Application (2019-2024)
        6.3.2 World Vaginal Fungi Infections Treatment Market Size by Application (2025-2030)
        6.3.3 World Vaginal Fungi Infections Treatment Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Pfizer Inc.
        7.1.1 Pfizer Inc. Details
        7.1.2 Pfizer Inc. Major Business
        7.1.3 Pfizer Inc. Vaginal Fungi Infections Treatment Product and Services
        7.1.4 Pfizer Inc. Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Pfizer Inc. Recent Developments/Updates
        7.1.6 Pfizer Inc. Competitive Strengths & Weaknesses
    7.2 Bausch Health Companies Inc
        7.2.1 Bausch Health Companies Inc Details
        7.2.2 Bausch Health Companies Inc Major Business
        7.2.3 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product and Services
        7.2.4 Bausch Health Companies Inc Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Bausch Health Companies Inc Recent Developments/Updates
        7.2.6 Bausch Health Companies Inc Competitive Strengths & Weaknesses
    7.3 ANI Pharmaceuticals
        7.3.1 ANI Pharmaceuticals Details
        7.3.2 ANI Pharmaceuticals Major Business
        7.3.3 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product and Services
        7.3.4 ANI Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 ANI Pharmaceuticals Recent Developments/Updates
        7.3.6 ANI Pharmaceuticals Competitive Strengths & Weaknesses
    7.4 Hikma Pharmaceuticals Plc
        7.4.1 Hikma Pharmaceuticals Plc Details
        7.4.2 Hikma Pharmaceuticals Plc Major Business
        7.4.3 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product and Services
        7.4.4 Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Hikma Pharmaceuticals Plc Recent Developments/Updates
        7.4.6 Hikma Pharmaceuticals Plc Competitive Strengths & Weaknesses
    7.5 Lupin Limited
        7.5.1 Lupin Limited Details
        7.5.2 Lupin Limited Major Business
        7.5.3 Lupin Limited Vaginal Fungi Infections Treatment Product and Services
        7.5.4 Lupin Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Lupin Limited Recent Developments/Updates
        7.5.6 Lupin Limited Competitive Strengths & Weaknesses
    7.6 Mycovia Pharmaceuticals
        7.6.1 Mycovia Pharmaceuticals Details
        7.6.2 Mycovia Pharmaceuticals Major Business
        7.6.3 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product and Services
        7.6.4 Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Mycovia Pharmaceuticals Recent Developments/Updates
        7.6.6 Mycovia Pharmaceuticals Competitive Strengths & Weaknesses
    7.7 Glenmark Pharmaceuticals Limited
        7.7.1 Glenmark Pharmaceuticals Limited Details
        7.7.2 Glenmark Pharmaceuticals Limited Major Business
        7.7.3 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product and Services
        7.7.4 Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 Glenmark Pharmaceuticals Limited Recent Developments/Updates
        7.7.6 Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
    7.8 Unique Pharmaceuticals
        7.8.1 Unique Pharmaceuticals Details
        7.8.2 Unique Pharmaceuticals Major Business
        7.8.3 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product and Services
        7.8.4 Unique Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 Unique Pharmaceuticals Recent Developments/Updates
        7.8.6 Unique Pharmaceuticals Competitive Strengths & Weaknesses
    7.9 PEPTONIC medical AB
        7.9.1 PEPTONIC medical AB Details
        7.9.2 PEPTONIC medical AB Major Business
        7.9.3 PEPTONIC medical AB Vaginal Fungi Infections Treatment Product and Services
        7.9.4 PEPTONIC medical AB Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 PEPTONIC medical AB Recent Developments/Updates
        7.9.6 PEPTONIC medical AB Competitive Strengths & Weaknesses
    7.10 Aurobindo Pharma Limited
        7.10.1 Aurobindo Pharma Limited Details
        7.10.2 Aurobindo Pharma Limited Major Business
        7.10.3 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product and Services
        7.10.4 Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Aurobindo Pharma Limited Recent Developments/Updates
        7.10.6 Aurobindo Pharma Limited Competitive Strengths & Weaknesses
    7.11 Dr. Reddy's Laboratories
        7.11.1 Dr. Reddy's Laboratories Details
        7.11.2 Dr. Reddy's Laboratories Major Business
        7.11.3 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product and Services
        7.11.4 Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Dr. Reddy's Laboratories Recent Developments/Updates
        7.11.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
    7.12 SCYNEXIS
        7.12.1 SCYNEXIS Details
        7.12.2 SCYNEXIS Major Business
        7.12.3 SCYNEXIS Vaginal Fungi Infections Treatment Product and Services
        7.12.4 SCYNEXIS Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 SCYNEXIS Recent Developments/Updates
        7.12.6 SCYNEXIS Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Vaginal Fungi Infections Treatment Industry Chain
    8.2 Vaginal Fungi Infections Treatment Upstream Analysis
    8.3 Vaginal Fungi Infections Treatment Midstream Analysis
    8.4 Vaginal Fungi Infections Treatment Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Vaginal Fungi Infections Treatment Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Vaginal Fungi Infections Treatment Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Vaginal Fungi Infections Treatment Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Vaginal Fungi Infections Treatment Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Vaginal Fungi Infections Treatment Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Vaginal Fungi Infections Treatment Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Vaginal Fungi Infections Treatment Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Vaginal Fungi Infections Treatment Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Vaginal Fungi Infections Treatment Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Vaginal Fungi Infections Treatment Players in 2023
    Table 12. World Vaginal Fungi Infections Treatment Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Vaginal Fungi Infections Treatment Company Evaluation Quadrant
    Table 14. Head Office of Key Vaginal Fungi Infections Treatment Player
    Table 15. Vaginal Fungi Infections Treatment Market: Company Product Type Footprint
    Table 16. Vaginal Fungi Infections Treatment Market: Company Product Application Footprint
    Table 17. Vaginal Fungi Infections Treatment Mergers & Acquisitions Activity
    Table 18. United States VS China Vaginal Fungi Infections Treatment Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Vaginal Fungi Infections Treatment Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Vaginal Fungi Infections Treatment Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Vaginal Fungi Infections Treatment Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Vaginal Fungi Infections Treatment Revenue Market Share (2019-2024)
    Table 23. China Based Vaginal Fungi Infections Treatment Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Vaginal Fungi Infections Treatment Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Vaginal Fungi Infections Treatment Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Vaginal Fungi Infections Treatment Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Vaginal Fungi Infections Treatment Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Vaginal Fungi Infections Treatment Revenue Market Share (2019-2024)
    Table 29. World Vaginal Fungi Infections Treatment Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Vaginal Fungi Infections Treatment Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Vaginal Fungi Infections Treatment Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Vaginal Fungi Infections Treatment Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Vaginal Fungi Infections Treatment Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Vaginal Fungi Infections Treatment Market Size by Application (2025-2030) & (USD Million)
    Table 35. Pfizer Inc. Basic Information, Area Served and Competitors
    Table 36. Pfizer Inc. Major Business
    Table 37. Pfizer Inc. Vaginal Fungi Infections Treatment Product and Services
    Table 38. Pfizer Inc. Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Pfizer Inc. Recent Developments/Updates
    Table 40. Pfizer Inc. Competitive Strengths & Weaknesses
    Table 41. Bausch Health Companies Inc Basic Information, Area Served and Competitors
    Table 42. Bausch Health Companies Inc Major Business
    Table 43. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Product and Services
    Table 44. Bausch Health Companies Inc Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Bausch Health Companies Inc Recent Developments/Updates
    Table 46. Bausch Health Companies Inc Competitive Strengths & Weaknesses
    Table 47. ANI Pharmaceuticals Basic Information, Area Served and Competitors
    Table 48. ANI Pharmaceuticals Major Business
    Table 49. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Product and Services
    Table 50. ANI Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. ANI Pharmaceuticals Recent Developments/Updates
    Table 52. ANI Pharmaceuticals Competitive Strengths & Weaknesses
    Table 53. Hikma Pharmaceuticals Plc Basic Information, Area Served and Competitors
    Table 54. Hikma Pharmaceuticals Plc Major Business
    Table 55. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Product and Services
    Table 56. Hikma Pharmaceuticals Plc Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Hikma Pharmaceuticals Plc Recent Developments/Updates
    Table 58. Hikma Pharmaceuticals Plc Competitive Strengths & Weaknesses
    Table 59. Lupin Limited Basic Information, Area Served and Competitors
    Table 60. Lupin Limited Major Business
    Table 61. Lupin Limited Vaginal Fungi Infections Treatment Product and Services
    Table 62. Lupin Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Lupin Limited Recent Developments/Updates
    Table 64. Lupin Limited Competitive Strengths & Weaknesses
    Table 65. Mycovia Pharmaceuticals Basic Information, Area Served and Competitors
    Table 66. Mycovia Pharmaceuticals Major Business
    Table 67. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Product and Services
    Table 68. Mycovia Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Mycovia Pharmaceuticals Recent Developments/Updates
    Table 70. Mycovia Pharmaceuticals Competitive Strengths & Weaknesses
    Table 71. Glenmark Pharmaceuticals Limited Basic Information, Area Served and Competitors
    Table 72. Glenmark Pharmaceuticals Limited Major Business
    Table 73. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Product and Services
    Table 74. Glenmark Pharmaceuticals Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. Glenmark Pharmaceuticals Limited Recent Developments/Updates
    Table 76. Glenmark Pharmaceuticals Limited Competitive Strengths & Weaknesses
    Table 77. Unique Pharmaceuticals Basic Information, Area Served and Competitors
    Table 78. Unique Pharmaceuticals Major Business
    Table 79. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Product and Services
    Table 80. Unique Pharmaceuticals Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. Unique Pharmaceuticals Recent Developments/Updates
    Table 82. Unique Pharmaceuticals Competitive Strengths & Weaknesses
    Table 83. PEPTONIC medical AB Basic Information, Area Served and Competitors
    Table 84. PEPTONIC medical AB Major Business
    Table 85. PEPTONIC medical AB Vaginal Fungi Infections Treatment Product and Services
    Table 86. PEPTONIC medical AB Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. PEPTONIC medical AB Recent Developments/Updates
    Table 88. PEPTONIC medical AB Competitive Strengths & Weaknesses
    Table 89. Aurobindo Pharma Limited Basic Information, Area Served and Competitors
    Table 90. Aurobindo Pharma Limited Major Business
    Table 91. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Product and Services
    Table 92. Aurobindo Pharma Limited Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Aurobindo Pharma Limited Recent Developments/Updates
    Table 94. Aurobindo Pharma Limited Competitive Strengths & Weaknesses
    Table 95. Dr. Reddy's Laboratories Basic Information, Area Served and Competitors
    Table 96. Dr. Reddy's Laboratories Major Business
    Table 97. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Product and Services
    Table 98. Dr. Reddy's Laboratories Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Dr. Reddy's Laboratories Recent Developments/Updates
    Table 100. SCYNEXIS Basic Information, Area Served and Competitors
    Table 101. SCYNEXIS Major Business
    Table 102. SCYNEXIS Vaginal Fungi Infections Treatment Product and Services
    Table 103. SCYNEXIS Vaginal Fungi Infections Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 104. Global Key Players of Vaginal Fungi Infections Treatment Upstream (Raw Materials)
    Table 105. Vaginal Fungi Infections Treatment Typical Customers
List of Figure
    Figure 1. Vaginal Fungi Infections Treatment Picture
    Figure 2. World Vaginal Fungi Infections Treatment Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Vaginal Fungi Infections Treatment Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Vaginal Fungi Infections Treatment Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Vaginal Fungi Infections Treatment Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Vaginal Fungi Infections Treatment Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Vaginal Fungi Infections Treatment Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Vaginal Fungi Infections Treatment Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Vaginal Fungi Infections Treatment Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Vaginal Fungi Infections Treatment Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Vaginal Fungi Infections Treatment Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Vaginal Fungi Infections Treatment Revenue (2019-2030) & (USD Million)
    Figure 13. Vaginal Fungi Infections Treatment Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Vaginal Fungi Infections Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Vaginal Fungi Infections Treatment Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Vaginal Fungi Infections Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Vaginal Fungi Infections Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Vaginal Fungi Infections Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Vaginal Fungi Infections Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Vaginal Fungi Infections Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Vaginal Fungi Infections Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Vaginal Fungi Infections Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Vaginal Fungi Infections Treatment by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Vaginal Fungi Infections Treatment Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Vaginal Fungi Infections Treatment Markets in 2023
    Figure 27. United States VS China: Vaginal Fungi Infections Treatment Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Vaginal Fungi Infections Treatment Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Vaginal Fungi Infections Treatment Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Vaginal Fungi Infections Treatment Market Size Market Share by Type in 2023
    Figure 31. Fluconazole
    Figure 32. Nystatin
    Figure 33. Flucytosine
    Figure 34. Others
    Figure 35. World Vaginal Fungi Infections Treatment Market Size Market Share by Type (2019-2030)
    Figure 36. World Vaginal Fungi Infections Treatment Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 37. World Vaginal Fungi Infections Treatment Market Size Market Share by Application in 2023
    Figure 38. Hospital Pharmacies
    Figure 39. Retail Pharmacies
    Figure 40. Online Pharmacies
    Figure 41. Vaginal Fungi Infections Treatment Industrial Chain
    Figure 42. Methodology
    Figure 43. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Pfizer Inc.
Bausch Health Companies Inc
ANI Pharmaceuticals
Hikma Pharmaceuticals Plc
Lupin Limited
Mycovia Pharmaceuticals
Glenmark Pharmaceuticals Limited
Unique Pharmaceuticals
PEPTONIC medical AB
Aurobindo Pharma Limited
Dr. Reddy's Laboratories
SCYNEXIS

Related Reports

Global Vaginal Fungi Infections Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global Vaginal Fungi Infections Treatment Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 08 Jan 2023

date Pharma & Healthcare

Vaginal candidiasis is usually treated with antifungal medicine. For most infections, the treatment is an antifungal medicine applied inside the vagina or a single dose of fluconazole taken by mouth.

Global Vaginal Fungi Infections Treatment Supply, Demand and Key Producers, 2023-2029

Global Vaginal Fungi Infections Treatment Supply, Demand and Key Producers, 2023-2029

date 20 Feb 2023

date Pharma & Healthcare

The global Vaginal Fungi Infections Treatment market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Vaginal Fungi Infections Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Vaginal Fungi Infections Treatment Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 12 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Vaginal Fungi Infections Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Vaginal Fungi Infections Treatment

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>